POR
NADPH--cytochrome P450 reductase
Also known as: CYPOR, FLJ26468, NCPR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P16435
- Gene
- POR
- Ensembl
- ENSG00000127948
- Chromosome
- 7
- Canonical length
- 677 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes an endoplasmic reticulum membrane oxidoreductase that is essential for multiple metabolic processes, including reactions catalyzed by cytochrome P450 proteins for metabolism of steroid hormones, drugs and xenobiotics. The encoded protein has a flavin adenine dinucleotide (FAD)-binding domain and a flavodoxin-like domain which bind two cofactors, FAD and FMN, that allow it to donate electrons directly from NADPH to all microsomal P450 enzymes. Mutations in this gene cause a complex set of disorders, including apparent combined P450C17 and P450C21 deficiency, amenorrhea and disordered steroidogenesis, congenital adrenal hyperplasia and Antley-Bixler syndrome, that resemble those caused by defects in steroid metabolizing enzymes such as aromatase, 21-hydroxylase, and 17 alpha-hydroxylase. [provided by RefSeq, Aug 2020]
Canonical amino-acid sequenceUniProt
677 residues, UniProt reviewed canonical sequence.
>P16435|POR
1 MGDSHVDTSS TVSEAVAEEV SLFSMTDMIL FSLIVGLLTY WFLFRKKKEE VPEFTKIQTL
61 TSSVRESSFV EKMKKTGRNI IVFYGSQTGT AEEFANRLSK DAHRYGMRGM SADPEEYDLA
121 DLSSLPEIDN ALVVFCMATY GEGDPTDNAQ DFYDWLQETD VDLSGVKFAV FGLGNKTYEH
181 FNAMGKYVDK RLEQLGAQRI FELGLGDDDG NLEEDFITWR EQFWPAVCEH FGVEATGEES
241 SIRQYELVVH TDIDAAKVYM GEMGRLKSYE NQKPPFDAKN PFLAAVTTNR KLNQGTERHL
301 MHLELDISDS KIRYESGDHV AVYPANDSAL VNQLGKILGA DLDVVMSLNN LDEESNKKHP
361 FPCPTSYRTA LTYYLDITNP PRTNVLYELA QYASEPSEQE LLRKMASSSG EGKELYLSWV
421 VEARRHILAI LQDCPSLRPP IDHLCELLPR LQARYYSIAS SSKVHPNSVH ICAVVVEYET
481 KAGRINKGVA TNWLRAKEPA GENGGRALVP MFVRKSQFRL PFKATTPVIM VGPGTGVAPF
541 IGFIQERAWL RQQGKEVGET LLYYGCRRSD EDYLYREELA QFHRDGALTQ LNVAFSREQS
601 HKVYVQHLLK QDREHLWKLI EGGAHIYVCG DARNMARDVQ NTFYDIVAEL GAMEHAQAVD
661 YIKKLMTKGR YSLDVWSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 293 nTPM
Expression across tissuesHPA
Tissue
- liver: 293 nTPM
- adrenal gland: 189 nTPM
- thyroid gland: 123 nTPM
- seminal vesicle: 107 nTPM
- duodenum: 100 nTPM
- small intestine: 87 nTPM
Single-cell type
- hepatocytes: 710 nCPM
- neutrophils: 513 nCPM
- enterocytes: 378 nCPM
- syncytiotrophoblasts: 263 nCPM
- esophageal apical cells: 217 nCPM
- proximal tubule cells: 192 nCPM
Immune cell
- basophil: 67 nTPM
- eosinophil: 60 nTPM
- neutrophil: 54 nTPM
- myeloid DC: 46 nTPM
- classical monocyte: 43 nTPM
- intermediate monocyte: 40 nTPM
Brain region
- hypothalamus: 81 nTPM
- thalamus: 63 nTPM
- midbrain: 62 nTPM
- medulla oblongata: 59 nTPM
- pons: 54 nTPM
- hippocampal formation: 54 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POR.
Disease | AllUniProt
Conditions POR is implicated in, by any mechanism.
- Antley-Bixler syndrome, with genital anomalies and disordered steroidogenesis (ABS1) MIM:201750
- Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) MIM:613571
Disease | GeneticClinVar
101 pathogenic / likely-pathogenic of 951 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
- Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis
- Congenital adrenal hyperplasia
- POR-related disorder
- Differences in sex development
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.07
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carnitine metabolic process
- cellular response to follicle-stimulating hormone stimulus
- cellular response to peptide hormone stimulus
- demethylation
- electron transport chain
- fatty acid oxidation
- flavonoid metabolic process
- negative regulation of apoptotic process
- nitric oxide biosynthetic process
- nitric oxide catabolic process
- organofluorine metabolic process
- P450-containing electron transport chain
- positive regulation of chondrocyte differentiation
- positive regulation of smoothened signaling pathway
- response to dexamethasone
- response to hormone
- response to nutrient
- response to xenobiotic stimulus
- nitrate catabolic process
- positive regulation of growth plate cartilage chondrocyte proliferation
- positive regulation of steroid hormone biosynthetic process
Molecular functions
- cytochrome-b5 reductase activity, acting on NAD(P)H
- electron transfer activity
- enzyme activator activity
- enzyme binding
- flavin adenine dinucleotide binding
- FMN binding
- hydrolase activity
- NADP binding
- NADPH-hemoprotein reductase activity
- iron-cytochrome-c reductase activity
- nitric oxide dioxygenase NAD(P)H activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Flavodoxin-like
- Oxidoreductase FAD/NAD(P)-binding
- Flavoprotein pyridine nucleotide cytochrome reductase
- Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding
- Flavodoxin/nitric oxide synthase
- FAD-binding domain, ferredoxin reductase-type
- Riboflavin synthase-like beta-barrel
- NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain superfamily
- Flavoprotein-like superfamily
- Ferredoxin-NADP reductase (FNR), nucleotide-binding domain
- Oxidoreductase NAD-binding domain
- Flavodoxin
- FAD binding domain
- NADPH-cytochrome P450 reductase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POR as an antibody target. Whether an autoantibody or antibody against POR could matter depends on whether native POR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...